Data / Form D filings / Clearmind Medicine Inc.
Clearmind Medicine Inc.: Form D filing
Clearmind Medicine Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2024. The latest, on February 7, 2024, reports $2.4 million sold of a $2.4 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 - 1220 WEST 6TH AVENUE, Vancouver, British Columbia, Canada, V6H1A
- Phone
- (973) 536-1016
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1892500
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | New notice | $2,400,000 | $2,400,000 | 12 | Jan 11, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yehonatan Shachar | Director | |
| Asaf Itzhaik | Director | |
| Dr. Adi Zuloff-Shani | Executive Officer | |
| Amitay Weiss | Director | |
| Alan Rootenberg | Executive Officer | |
| Oz Adler | Director | |
| Prof. Mark Haden | Executive Officer |
Every Form D from the week of Feb 5, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Clearmind Medicine Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.